Primary Care Companion
PPP
Login  

This entire article is available in Full Text to registered users.

 

The article you requested is

Methylphenidate-Induced Akathisia in a Patient With Multiple Sclerosis

Prim Care Companion J Clin Psychiatry 2006;8(6):379-380 [letter]
10.4088/PCC.v08n0611d

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Methylphenidate is a short-acting psychostimulant that is structurally and pharmacologically similar to dextroamphetamine and is primarily used in the treatment of attention-deficit/ hyperactivity disorder (ADHD).1,2 Its use has also been explored for the treatment of apathy and for augmentation of effects of antidepressants.3 It acts as a dopaminergic and noradrenergic reuptake inhibitor.​